Viewing nowJayrosu 5mg (Rosuvastatin Calcium)
Rosuvastatin Calcium Micronized 5.2mg
Tablet · Prescription medication
Jeil Pharmaceutical Co., Ltd.

MFDS item code 201702527 · Approved 2017.05.23 · Insurance code 645405200
Improvement of dyslipidemia, inhibition of atherosclerosis progression, and prevention of cardiovascular disease
This medicine is primarily used when dietary management and exercise alone are insufficient for controlling primary hypercholesterolemia and combined hyperlipidemia in patients. It is especially used as an adjunct to lipid control in patients with familial hypercholesterolemia, which helps lower total cholesterol and LDL cholesterol levels, thereby slowing the progression of atherosclerosis. Additionally, it is used in certain pediatric patients to control high cholesterol levels that remain despite dietary adjustments. It is also used alongside dietary management in patients with dysbetalipoproteinemia (DBL). In patients at high risk for cardiovascular disease, it is effective in reducing the risk of stroke, myocardial infarction, and arterial revascularization procedures. Therefore, this drug is used for hyperlipidemia and reducing the risk of cardiovascular disease.
Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine, and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily; if a greater reduction in LDL cholesterol is needed, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 milligrams once daily, which is sufficient to control the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response; the dose may be increased to a maximum of 20 milligrams per day. Elderly patients: No dose adjustment is required. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20mg of this medicine to patients with moderate renal impairment. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of a 40-milligram dose is contraindicated. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of a 40-milligram dose of this medicine is contraindicated in some of these patients.
Pediatric patients with heterozygous familial hypercholesterolemia (aged 10 to 17 years): The usual dose range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses higher than 20 milligrams in pediatric patients.) The dose should be individually adjusted according to the recommended treatment goal for each patient. Adjust the dose at intervals of 4 weeks or longer. Safety and efficacy in children under 10 years of age have not been established.
This medicine should not be administered to certain patients. For example, individuals allergic to any component of this medicine or those with severe liver dysfunction should not use it. Patients with muscle disorders or those taking specific immunosuppressants should also avoid this medication. Women who are pregnant or breastfeeding, as well as fertile women who do not practice appropriate contraception, should avoid using this medicine. This medication contains lactose, so it is not suitable for patients with lactose intolerance. Regular monitoring of liver function and muscle health is required while using this drug. Caution is especially needed in individuals who consume excessive alcohol or have liver disease. If symptoms such as muscle pain or weakness occur, medical personnel should be informed immediately. Older adults, as well as individuals with impaired renal function or hypothyroidism, should use this medication cautiously. Because this drug may interact with other medications, it is essential to inform healthcare providers of any other drugs being taken. The risk of muscle abnormalities may increase when taken with certain antibiotics, antifungals, immunosuppressants, or fibrate class medications. This drug should not be used during pregnancy, and women planning to become pregnant should consult with a healthcare provider before use. It is also advisable to avoid this medication while breastfeeding, as it may be transmitted through breast milk. In case of overdose, there is no specific antidote, so one should seek appropriate medical treatment immediately. Caution is advised when driving or operating machinery, as dizziness may occur after taking this medication. Regular check-ups to monitor liver and muscle health during the treatment period are crucial.
Allergic reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, asthenia, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ophthalmoplegia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, eosinophilia, and drug reaction with eosinophilia and systemic symptoms, drug-induced exanthema, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, numbness, paresthesia, chest discomfort, loss of appetite, abdominal distension, syncope, generalized pain, fatigue
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it should be stored in a tightly closed container. The recommended storage temperature is room temperature between 1 degree and 30 degrees Celsius. This will help ensure the safety and effectiveness of the medication.
Yellow round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium Micronized 5.2mg
Tablet · Prescription medication
Jeil Pharmaceutical Co., Ltd.

Rosuvastatin Calcium Micronized 20.8mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Rosuvastatin Calcium Micronized 5.2mg
Tablet · Prescription medication
Daiwoo Pharmaceutical Co., Ltd.

Rosuvastatin Calcium Micronized 10.4mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Rosuvastatin Calcium Micronized 10.4mg
Tablet · Prescription medication
Hanin Pharmaceutical Co., Ltd.

Rosuvastatin Calcium Micronized 10.4mg
Tablet · Prescription medication
Myungjin Pharmaceutical Co., Ltd.

Rosuvastatin Calcium Micronized 5.2mg
Tablet · Prescription medication
Teragen Itex Co., Ltd.

Rosuvastatin Calcium Micronized 10.4mg
Tablet · Prescription medication
Teragen Etex Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.